A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19.
Bowdish ME, Barkauskas CE, Overbey JR, Gottlieb RL, Osman K, Duggal A, Marks ME, Hupf J, Fernandes E, Leshnower BG, Golob JL, Iribarne A, Rassias AJ, Moquete EG, O'Sullivan K, Chang HL, Williams JB, Parnia S, Patel NC, Desai ND, Vekstein AM, Hollister BA, Possemato T, Romero C, Hou PC, Burke E, Hayes J, Grossman F, Itescu S, Gillinov M, Pagani FD, O'Gara PT, Mack MJ, Smith PK, Bagiella E, Moskowitz AJ, Gelijns AC.
Bowdish ME, et al.
Am J Respir Crit Care Med. 2023 Feb 1;207(3):261-270. doi: 10.1164/rccm.202201-0157OC.
Am J Respir Crit Care Med. 2023.
PMID: 36099435
Free PMC article.
Clinical Trial.